Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 36,000 | 177,000 | 149,600 | 90,600 | 53,600 |
| Depreciation Amortization | 19,800 | 72,700 | 52,200 | 32,100 | 15,600 |
| Income taxes - deferred | -5,700 | -39,600 | -7,300 | 9,000 | 6,000 |
| Accounts receivable | -12,700 | -9,000 | -18,100 | -34,500 | -17,600 |
| Accounts payable and accrued liabilities | 33,400 | -1,700 | -9,200 | 21,700 | 12,900 |
| Other Working Capital | -56,300 | 41,300 | -25,500 | -53,500 | -61,300 |
| Other Operating Activity | -65,600 | 73,000 | 44,300 | 14,400 | 23,100 |
| Operating Cash Flow | $-51,100 | $313,700 | $186,000 | $79,800 | $32,300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -49,000 | -145,300 | -84,300 | -50,400 | -19,700 |
| Net Acquisitions | N/A | -449,300 | -445,400 | -28,600 | -28,600 |
| Other Investing Activity | 11,800 | 84,700 | 97,400 | -8,500 | -1,200 |
| Investing Cash Flow | $-37,200 | $-509,900 | $-432,300 | $-87,500 | $-49,500 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 5,000 | -500 | 2,900 | 7,000 | 4,500 |
| Debt Issued | 624,400 | 318,100 | 214,200 | 212,000 | 2,000 |
| Debt Repayment | -511,600 | -268,400 | -202,400 | -40,800 | N/A |
| Common Stock Issued | 8,800 | 28,000 | 19,700 | 16,300 | 13,400 |
| Common Stock Repurchased | -89,700 | -99,900 | 0 | 0 | N/A |
| Dividend Paid | -7,400 | -25,900 | -20,200 | -14,500 | -8,700 |
| Other Financing Activity | 2,100 | 4,600 | 3,500 | 3,800 | 2,000 |
| Financing Cash Flow | $31,600 | $-44,000 | $17,700 | $183,800 | $13,200 |
| Exchange Rate Effect | -2,100 | 3,700 | 2,300 | -1,300 | 7,900 |
| Beginning Cash Position | 179,300 | 415,800 | 415,800 | 415,800 | 415,800 |
| End Cash Position | 120,500 | 179,300 | 189,500 | 590,600 | 419,700 |
| Net Cash Flow | $-58,800 | $-236,500 | $-226,300 | $174,800 | $3,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,100 | 313,700 | 186,000 | 79,800 | 32,300 |
| Capital Expenditure | -49,000 | -145,300 | -84,300 | -50,400 | -19,700 |
| Free Cash Flow | -100,100 | 168,400 | 101,700 | 29,400 | 12,600 |